These medicines are used along with a reduced-calorie eating plan and exercise program
Safety and Clinical Management Safety trials of GLP-1 RAs, including liraglutide, tirzepatide, and semaglutide (oral or subcutaneous), indicate that the most common adverse events (AEs) of treatment are mild to moderate gastrointestinal including nausea, vomiting, diarrhea, constipation, dyspepsia, and decreased appetite
Collectively, ROS-induced mtDNA damage, m dissipation, mPTP activation, and Ca 2+ dysregulation converge to drive mitochondrial collapse, ATP depletion, and skeletal myocyte apoptosis or necrosis-ultimately contributing to the pathogenesis of muscle atrophy (Chen et al., 2023)
They are sometimes prescribed by dermatologists to maintain the effects of the injection
NSAIDs also have harmful effects on the liver, kidneys, GI tract and cardiovascular system, while steroids can affect blood sugar levels and cause weight gain, exacerbating metabolic issues that contribute to knee OA